318. Citrin deficiency Clinical trials / Disease details


Clinical trials : 2 Drugs : 2 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0

  
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2000038114
2020-09-152020-09-11Molecular Diagnostic Study and Clinical Management of citrin deficiencyMolecular Diagnostic Study and Clinical Management of citrin deficiency Citrin deficiencyGold Standard:Sanger sequncing;Index test:Next-Generation Sequncing;Beijing Friendship Hospital Affiliated to Capital Medical UniversityNULLRecruitingBothTarget condition:60;Difficult condition:0N/AChina
2JPRN-jRCTs041190017
31/07/201210/04/2019Confirmation of effects of medium chain triglyceride therapy for citrin deficiencyConfirmation of effects of medium chain triglyceride therapy for citrin deficiency, especially in patients with symptomatic post neonatal intrahepatic cholestasis and that with adult-onset type II citrullinemia citrin deficiency
Endocrinology and Metabolism, Pediatrics;D006111
Medium chain triglyceride 5-15ml 3 times a dayMitsui TetsuoNULLRecruitingNot applicable80ageBoth50Phase 2Japan